|
Castillo-González AC, Pelegrín-Hernández JP, Nieto-Cerón S, Madrona AP, Noguera JA, López-Moreno MF, Rodríguez-López JN, Vidal CJ, Hellín-Meseguer D, Cabezas-Herrera J. Unbalanced acetylcholinesterase activity in larynx squamous cell carcinoma. Int Immunopharmacol. 2015 Nov;29(1):81-6. doi: 10.1016/j.intimp.2015.05.011. PubMed PMID: 26002584.
AÑO: 2015; IF: 2.551
|
26002584
|
Castillo-González AC, Nieto-Cerón S, Pelegrín-Hernández JP, Montenegro MF, Noguera JA, López-Moreno MF, Rodríguez-López JN, Vidal CJ, Hellín-Meseguer D, Cabezas-Herrera J. Dysregulated cholinergic network as a novel biomarker of poor prognostic in patients with head and neck squamous cell carcinoma. BMC Cancer. 2015 May 10;15:385. doi: 10.1186/s12885-015-1402-y. PubMed PMID: 25956553; PubMed Central PMCID: PMC4435806.
AÑO: 2015; IF: 3.15
|
|
Montenegro MF, Nieto-Cerón S, Cabezas-Herrera J, Muñoz-Delgado E, Campoy FJ, Vidal CJ. Most acetylcholinesterase activity of non-nervous tissues and cells arises from the AChE-H transcript. J Mol Neurosci. 2014 Jul;53(3):429-35. doi: 10.1007/s12031-013-0172-8. PubMed PMID: 24242952.
AÑO: 2014; IF: 2.343
|
|
Martínez-Ruiz A, Sarabia-Meseguer MD, Pérez-Fornieles J, Vílchez JA, Tovar-Zapata I, Noguera-Velasco JA. Placental growth factor, soluble fms-like tyrosine kinase 1 and progesterone as diagnostic biomarkers for ectopic pregnancy and missed abortion. Clin Biochem. 2014 Jun;47(9):844-7. doi: 10.1016/j.clinbiochem.2014.03.013. PubMed PMID: 24699433.
AÑO: 2014; IF: 2.275
|
|
Sáez-Ayala M, Montenegro MF, Sánchez-Del-Campo L, Fernández-Pérez MP, Chazarra S, Freter R, Middleton M, Piñero-Madrona A, Cabezas-Herrera J, Goding CR, Rodríguez-López JN. Directed phenotype switching as an effective antimelanoma strategy. Cancer Cell. 2013 Jul 8;24(1):105-19. doi: 10.1016/j.ccr.2013.05.009. PubMed PMID: 23792190.
AÑO: 2013; IF: 26.602
|